EGFR and glioblastoma: In this study, we showed that the invasion factor ODZ1 is upregulated by an EGFR–p38-MAP-kinase signaling pathway that might explain, at least in part, the higher migration capacity of GBM cells in the presence of EGF, which is highly reduced through the blockade of this pathway.